Abstract

Objective: The purpose was to confirm the significance of Anti-endothelial cell antibodies(AECA) in chronic obstructive pulmonary disease (COPD) and validate the effect of methylprednisolone intervention.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title
Journal
Date
Author
COPD—more than just tobacco smoke
The Lancet
The Lancet | VOL. 374
The Lancet The Lancet
01 Aug 2009
Introduction
Robert A Wise ... Donald P Tashkin
The American Journal of Medicine | VOL. 120
Robert A Wise, et. al.Robert A Wise ... Donald P Tashkin
01 Aug 2007
Maintenance pharmacotherapy of mild and moderate COPD: What is the Evidence?
Gary T Ferguson
British Journal of Diseases of the Chest | VOL. 105
Gary T FergusonGary T Ferguson
25 Feb 2011
De novo development of circulating anti-endothelial cell antibodies rather than pre-existing antibodies is associated with post-transplant allograft rejection
Qiquan Sun ... Zhihong Liu
Kidney International | VOL. 79
Qiquan Sun, et. al.Qiquan Sun ... Zhihong Liu
01 Mar 2011
View more papers

More From: Inflammation and Cell Signaling

Paper Title
Journal
Date
Author
The value of diagnostic model on COVID-19 by Comparing the Features between SARS-COV-2 and other viral infections
-
Inflammation and Cell Signaling | VOL. -
--
21 Apr 2022
A case that high doses of Vitamin C as a potential therapy for COVID-19
-
Inflammation and Cell Signaling | VOL. -
--
21 Apr 2022
Plasma level of M-CSF was independently related to 30-day survival in patients with suspected sepsis, and correlated to pathogen load: A prospective cohort study
-
Inflammation and Cell Signaling | VOL. -
--
21 Apr 2022
A study on the significance of anti-endothelial cell antibodies in chronic obstructive pulmonary disease and the effect of methylprednisolone intervention
-
Inflammation and Cell Signaling | VOL. -
--
21 Apr 2022
View more papers